Literature DB >> 5923087

Herpes simplex encephalitis treated with systemic 5-iodo-2'deoxyuridine.

C J Breeden, T C Hall, H R Tyler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5923087     DOI: 10.7326/0003-4819-65-5-1050

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  24 in total

1.  Antiviral chemotherapeutic agents.

Authors:  J E Miller
Journal:  Can Med Assoc J       Date:  1968-10-12       Impact factor: 8.262

Review 2.  Herpes simplex virus infections of the central nervous system. Encephalitis and neonatal herpes.

Authors:  R J Whitley
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

3.  Herpes simplex encephalitis: treatment with surgical decompression and cytosine arabinoside.

Authors:  R K Laha; F W Saunders; W S Huestis
Journal:  Can Med Assoc J       Date:  1976-08-07       Impact factor: 8.262

4.  [Herpes simplex encephalitis in newborns. Treatment with 5-iodo-2'-deoxyuridin? (author's transl)].

Authors:  R Nüssli; H P Kind; G Duc
Journal:  Eur J Pediatr       Date:  1976-05-04       Impact factor: 3.183

Review 5.  New indications for 6-azauridine treatment in man. A review.

Authors:  J Elis; H Rasková
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

Review 6.  Antiviral chemotherapy: the first decade.

Authors:  D J Bauer
Journal:  Br Med J       Date:  1973-08-04

7.  Editorial: Hepatitis and herpesvirus.

Authors: 
Journal:  Br Med J       Date:  1974-08-24

8.  Approach to diagnosis and treatment of herpes simplex encephalitis. A report of two cases.

Authors:  M J Gurwith; C E Harman; T C Merigan
Journal:  Calif Med       Date:  1971-12

9.  Immunofluorescence staining for the diagnosis of herpes encephalitis.

Authors:  A H Tomlinson; I J Chinn; F O MacCallum
Journal:  J Clin Pathol       Date:  1974-06       Impact factor: 3.411

10.  Herpes encephalitis. I. The clinical picture.

Authors:  A M Campbell
Journal:  Postgrad Med J       Date:  1969-06       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.